Hims & Hers Health Faces Securities Fraud Lawsuit, Investors Urged to Act

Rosen Law Firm, an investor rights law firm, has announced a lead plaintiff deadline for a securities fraud lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS). The firm is alerting investors who purchased the company's securities during the period of August 4, 2025, through July 29, 2026, that they may be entitled to compensation without incurring out-of-pocket fees.

The lawsuit alleges that Hims & Hers made materially false and misleading statements and failed to disclose crucial information. According to the complaint, the company shared consumer health data with third-party advertising platforms. It also claims Hims & Hers charged consumers for prescriptions immediately after intake, contrary to promises of consulting on suitable treatments. These practices allegedly subjected the company to regulatory scrutiny and potential penalties.

Rosen Law Firm emphasizes the importance for investors to select legal counsel with a proven track record in securities class actions. The firm positions itself as experienced in this area, handling cases globally and recovering significant sums for investors.

Interested parties must act by November 2, 2026, to potentially serve as lead plaintiff, a representative party in the litigation. Further details and options for participation are available through Rosen Law Firm's website and provided contact information.